Cases & Deals

TxCell completes €11 million rights issue

Clients TxCell SA

Jones Day advised TxCell SA, a biotech company specializing in innovative, personalized cell-based immunotherapies, and Invest Securities, as lead manager and bookrunner, in connection with the €11 million (US$11.6 million) rights issue of new shares with warrants attached.